The Supreme Court granted a request by the Department of Justice and the abortion pill maker Danco Laboratories to review a Fifth Circuit Court decision drastically limiting access to the abortion pill mifepristone. At the same time, the Supreme Court denied a request by the anti-abortion group Alliance for Hippocratic Medicine to reinstate a Texas district court decision staying the 2000 approval of mifepristone.

The case will be heard this term, with a decision likely by summer—just months before the next election, where voters will decide on the next U.S. president and who will represent them in Congress. While the Supreme Court considers the case, the medication will remain available as it has been.